CEA Antikörper

Produktnummer ABIN969047

Produktdetails anti-CEA Antikörper

Target: CEA (Carcinoembryonic Antigen Gene Family (CEA))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CEA Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (IHC), ELISA

Verwendungszweck: CEA Antibody

Aufreinigung: Ascitic fluid

Immunogen: Purified recombinant fragment of human CEA expressed in E. Coli.

Klon: 1C7

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: ELISA: 1/10000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Ascitic fluid containing 0.03 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Referenzen für anti-CEA Antikörper (ABIN969047)

Bjerner, Høgetveit, Wold Akselberg, Vangsnes, Paus, Bjøro, Børmer, Nustad: "Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study." in: Scandinavian journal of clinical and laboratory investigation, Vol. 68, Issue 8, pp. 703-13, (2008) (PubMed).

Huang, Wang, Yang, Yin, Geng, Li: "[Clinical value of combined determination of serum and pleural effusion level of CEA,CYFRA21-1, TPS in the diagnosis of lung cancer]." in: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, Vol. 24, Issue 4, pp. 370-2, (2008) (PubMed).

Details zu CEA

Target: CEA (Carcinoembryonic Antigen Gene Family (CEA))

Andere Bezeichnung: CEA (CEA Produkte)

Synonyme: RGD1311281 antikoerper, carcinoembryonic antigen-related cell adhesion molecule 20 antikoerper, carcinoembryonic antigen gene family antikoerper, Ceacam20 antikoerper, Cea antikoerper

Hintergrund:

Description: Carcino Embryonic Antigen (CEA) is synthesised during development in the fetal gut, and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibodies to CEA are useful in identifying the origin of various metastatic adenocarcinomas and in distinguishing pulmonary adenocarcinomas (60 to 70 % are CEA+) from pleural mesotheliomas (rarely or weakly CEA+).The carcinoembryonic antigen (CEA) is a member of a large family of glycoproteins and a useful tumor marker for adenocarcinoma.Tissue specificity: Found in adenocarcinomas of endodermally derived digestive system epithelium and fetal colon.

Aliases: CEA, CD66e, DKFZp781M2392, CEACAM5

Molekulargewicht: 77kDa

Gen-ID: 1048

HGNC: 1048

UniProt: P06731